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The resurgence of TB springs mainly from inadequate2 INSERM U447
Institut Pasteur de Lille drug compliance, the appearance of drug-resistant
strains, and the facile infection of victims of the AIDS1 rue du Pr. Calmette
BP245-59019 Lille Cedex epidemic. The response by the World Health Organiza-
tion (WHO) to the compliance problem has been theFrance
recommendation of “directly observed therapy” (DOT),
an ambitious program in which patients are monitored
individually. Drug-resistant strains appear to have arisenMycobacterium tuberculosis continues to be the pre-
following inadequate adherence to recommended drugdominant global infectious agent, annually killing over
regimens; this is particularly serious in certain parts ofthree million people. Recommended drug regimens
the world as widespread as Eastern Europe, Centralhave the potential to control tuberculosis, but lack
Africa, and pockets of USA. The only real solution toof adherence to such regimens has resulted in the
avoid AIDS patients succumbing to TB is to eradicateemergence of resistant strains. Mycobacterium tuber-
the viral condition, and this is bound to be a long haul,culosis has an unusual cell envelope, rich in unique
depending heavily on education and political directives.long-chain lipids, that provides a very hydrophobic
It is currently postulated that the distinctive pathoge-barrier to antibiotic access. Such lipids, however, can
nicity of M. tuberculosis can be correlated with the pres-be drug targets, as exemplified by the action of the
ence of an unusual cell envelope, rich in unusual poly-front-line drug isoniazid on mycolic acid biosynthesis.
saccharides and lipid components, as will be detailedA number of these lipids are potential key virulence
below. To accelerate progress in the battle against TB,factors and their structures are based on very charac-
it is imperative that a full understanding of the structure,teristic methyl-branched long-chain acids and alco-
function, and biosynthesis of the mycobacterial cell en-hols. This review details the history, structure, and
velope is attained without delay. The determination ofgenetic aspects of the biosynthesis of these methyl-
the complete genome of M. tuberculosis [2] providesbranched components, good examples of which are
access to the full range of biosynthetic pathways leadingthe phthiocerols and the mycocerosic and mycolipenic
to the assembly of the cell envelope. This review willacids.
highlight the structure and biosynthesis of multimethyl-
branched fatty acids and methyl-branched long-chain
Introduction diols in M. tuberculosis.
Tuberculosis (TB) remains a terrible scourge in many
parts of the world and annually kills over three million
people [1]. This fact clearly establishes Mycobacterium The Lipid Components of M. tuberculosis
tuberculosis as the predominant global infectious agent. The unusual lipophilic nature of the cell envelope of the
Two decades ago, it was generally considered that TB, tubercle bacillus was clearly indicated by pioneering
and indeed the closely related mycobacterial disease studies in the 1930s coordinated by R.J. Anderson at
of leprosy, were under control and that it was just a Yale [4]. It was shown that high proportions of unique
matter of time before they faded into history. Throughout long-chain compounds were present, and the so-called
the 1980s and 1990s, however, both TB and leprosy mycolic acids were characterized for the first time. In
have been encouraged to reestablish themselves due the 1950s and 1960s, the essential structural details of
to a number of factors. Regarding leprosy, it has been these lipids were determined in the laboratories of E.
mainly a matter of problems in ensuring effective medi- Lederer (Paris), J. Asselineau (Paris and Toulouse), and
cal and nursing care. Compared with TB, it is much more N. Polgar (Oxford), as reviewed by Asselineau [5], Goren
difficult to catch leprosy, its main transmission route and Brennan [6], and Minnikin [7]. Research during the
being through repeated bodily contact rather than an past thirty years has consolidated knowledge of the struc-
unselective aerosol mode. Therefore, expectations of ture of the lipids of M. tuberculosis; details of the studies
bringing leprosy under control remain high, even though leading to these structures can be found in recent re-
it is currently impossible to cultivate the causative agent, views [8, 9]. The principal structures of complex lipids
Mycobacterium leprae, and to directly study its bio- from the M. tuberculosis complex are introduced in Fig-
chemistry in detail. Alternatively, genomic comparison ures 1 and 2, and a model for their possible interaction
between the leprosy and tubercle bacilli offers an indi- in the cell envelope is shown in Figure 3; further details
rect approach for the development of new drugs and will be discussed below.
The mycolic acids are the key lipid components in M.
tuberculosis, and their essential structures are repre-3 Correspondence: d.e.minnikin@bham.ac.uk
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Figure 1. Structures of M. tuberculosis Mycolic Acids and Glycolipids, Based on Trehalose
(A) Schematic representation of the , methoxy-, and ketomycolic acids from M. tuberculosis.
(B) Trehalose dimycolate (TDM) from M. tuberculosis.
(C) Complex glycolipids from M. tuberculosis. Sulfated tetra-acyl trehalose (SL1) based on phthioceranic and hydroxyphthioceranic acids,
diacyl trehaloses (DAT1) based on mycosanoic acids, triacyl trehalose (TAT) and pentaacyl trehalose (PAT) based on mycolipenic acids.
sented in Figure 1A. Mycolic acids, with related struc- to be a pentaacyl trehalose (PAT) (Figure 1C). Some
strains also had related triacyl trehaloses (TATs), withtures, are also present in all mycobacteria and related
actinomycetes [10]. Although the structures of these the possible structure shown in Figure 1C [17].
Other members of the M. tuberculosis complex canunique lipids have been well characterized, the enzymol-
ogy and genetics leading to their biosynthesis have only have alternative characteristic glycolipids antigens. My-
cobacterium bovis, Mycobacterium africanum, Myco-recently begun to be elucidated [11]. As shown later,
mycolic acids are predominately covalently bound to bacterium microti, and the attenuated Mycobacterium
bovis BCG variant produce a phenolic glycolipid (Figurean arabinogalactan polysaccharide; some, however, are
found as trehalose monomycolates (TMM) and dimyco- 2A), the so-called mycoside B [5–7, 18]. The unusual
M. tuberculosis “Canetti” strains, with smooth colonylates (TDM) (Figure 1B); TMM is involved in the transfer
of mycolic acids into the cell wall [12]. morphology, are characterized by the presence of unique
phenolic glycolipids [19] and lipo-oligosaccharides [20].M. tuberculosis is characterized by a range of complex
glycolipids based on trehalose (Figure 1C). A family of Two M. tuberculosis clinical isolates, labeled O and K,
also produced phenolic glycolipids, although they hadsulfated acyl trehaloses (SL) were characterized in early
studies by Goren and coworkers [6, 13], the principal the usual rough morphology [21]. In this survey, attention
will be restricted to lipids of the more usual strains ofglycolipid being termed SL1 (Figure 1C). A pair of closely
related diacyl trehaloses (DAT1 and DAT2) were isolated M. tuberculosis and M. bovis.
The dimycocerosates of the phthiocerol family (PDIMs)from M. tuberculosis [14], and DAT1 was shown to have
the structure in Figure 1C, based on a mycosanoic acid (Figure 2B) are major waxes, related to the phenolic
glycolipids, which are found in most representatives of(Figure 4). The more polar DAT2 glycolipid had a mycoli-
panolic acid (Figure 4) in place of the mycosanoate. M. tuberculosis and some other related mycobacteria.
These waxes (Figure 2B) and glycolipids based on treha-These lipids cooccurred with more heavily acylated gly-
colipids [15], whose main component was shown [16] lose (Figure 1C) are characterized by the presence of a
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Figure 2. Structures of M. tuberculosis Complex Mycoside B, Phthiocerol Dimycocerosate, and Related Genomics
(A) Mycoside B (PGL) from M. bovis BCG.
(B) Phthiocerol dimycocerosate A (PDIM A) from M. tuberculosis.
(C) The genomic organization of surrounding open reading frames that produce and transport PGL/PDIM.
range of multimethyl-branched fatty acids, and a de- culosis were characterized over an extended period fol-
lowing the pioneering studies of Anderson [4]. Pro-tailed consideration of these long-chain components is
the main subject of this review. Lipids containing longed hydrolysis of resistant waxes gave laevorotatory
“mycocerosic” acids [25]; the trimethyl- and tetra-multimethyl-branched fatty acids were proposed [7] to
interact with a covalently bound monolayer of mycolic methyl-branched (Figure 4) structures were elaborated
by Marks and Polgar [26]. The principal componentsacids to provide a characteristic mycobacterial outer-
membrane organelle. Subsequent studies [22, 23] have of Anderson’s dextrorotatory “phthioic” acids [4] were
shown by Chanley and Polgar [27] to be ,-unsaturatedsupported this hypothesis, and direct evidence for two
distinct envelope lipid domains has been given by pref- “mycolipenic” acids (Figure 4), a finding echoed by Ca-
son and Sumrell [28], who named them “phthienoic”erential location of fluorescent probes of different
lipophilicity [24]. The essence of the cell envelope orga- acids. The same extracts yielded lesser proportions of
“mycolipodienic” and “mycolipanolic” (Figure 4) acidsnization is provided in Figure 3. Briefly, a relatively con-
ventional plasma membrane and peptidoglycan is con- [29, 30]. Related “mycosanoic” acids (Figure 4) were
characterized by Cason et al. [31]. Acylated trehalosenected by a linker unit (LU) to an arabinogalactan, which
bears the mycolic acids on some of its arabinose termini. sulfates were found by Goren et al. [6, 13] to be based on
dextrorotatory heavily branched “phthioceranic” (FigurePredominant components in the cell envelope of M. tu-
berculosis are the lipoarabinomannan (LAM) and related 4) and “hydroxyphthioceranic” (Figure 4) acids.
The name “phthiocerol” was given to a long-chainlipomannan (LM), which is not included in Figure 3. LAM
and LM are lipopolysaccharides based on a phosphati- methoxyglycol by Stodola and Anderson [32]. Key deg-
radative studies by Hall and Polgar [33] lead to the es-dylinositol mannoside (PIM) anchors, which may locate
into the plasma membrane (Figure 3). sential structure of phthiocerol A (Figure 5) as 3-methoxy-
4-methyl do- (and tetra)-triacontane-9,11-diol [34, 35]The multimethyl-branched fatty acids from M. tuber-
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fatty acids using malonyl-CoA. Mycobacterial FAS I is
much larger than other multifunctional synthases, prob-
ably accounting for its unusual elongating activities. The
domain organization of FAS I is like a head-to-tail fusion
of two yeast FAS subunits: acyl transferase (AT), enoyl
reductase (ER), dehydratase (DH), malonyl-palmitoyl
transferase-acyl carrier protein (ACP) fused with -keto-
reductase (KR), and -ketoacyl synthase (KS) [43]. No
additional AT or KS domains, uniquely involved in chain
elongation, were found. However, a putative active site
sequence for a second nucleotide binding KR domain
was apparent. The need for both NADH and NADPH for
mycobacterial FAS I, in contrast to the single-reductant
requirement of other FASs, presumably reflects this ob-
servation.
Figure 3. Arrangement of Structural Components in the Cell Enve-
lope of M. tuberculosis, Showing Possible Interaction of Methyl-
Biosynthesis of Multimethyl-Branched Fatty AcidsBranched Long-Chain Components with a Mycolic Acid Matrix
The biosynthesis of multimethyl-branched fatty acidsMycolyl arabinogalactan (mAG) is connected by a phosphoryl linker
involves methylmalonyl-CoA as the chain-extendingunit to peptidoglycan (PG). Complex free lipids (PDIM, DAT, PAT,
SL; see Figures 1 and 2) interact with mAG. Lipoarabinomannan substrate, in contrast to malonyl-CoA for n-fatty acids.
(LAM) and phosphatidylinositol pentamannoside (PIM5) are shown Vertebrate FAS I preparations are capable of synthesiz-
anchored in the plasma membrane. The mAG galactan is shown in ing 2, 4, 6, 8-tetra methyl-branched fatty acids when
yellow, and the LAM mannose components are in dark green; the
methylmalonyl-CoA is provided as an elongation sub-arabinan of both these polysaccharides is represented in light blue.
strate from short (C2 or C3) primers [44]. The structuresModified from references [7] and [22]. The figure is principally de-
of methyl-branched acids in M. tuberculosis suggestsigned to indicate the possible location and interactions of the
methyl-branched components; the outermost carbohydrate/pro- that they are not formed via a multienzyme FAS I com-
tein-rich layer [23] is omitted for clarity. plex but by a unique family of pks enzymes. Rainwater
and Kolattukudy developed a cell-free synthesis of my-
cocerosic acids from C20-CoA and methylmalonyl-CoA
from the PDIM waxes (Figure 2B). Compounds related and purified the enzyme to homogeneity from M. bovis
to phthiocerol A were thoroughly characterized as phthi- BCG [45, 46]. The mycocerosic acid synthase (MAS)
ocerol B (Figure 5) and phthiodiolone A (Figure 5) by was found to be a multifunctional synthase, similar to
Minnikin and Polgar [36, 37]. Smith and coworkers [38] FAS I, producing C27-C32 mycocerosic acids from
detected a glycolipid from M. bovis that was shown [39] straight-chain precursors (Figure 4). Subsequent clon-
to be based on a phenolphthiocerol unit (Figure 5), 2-O- ing and sequencing of mas revealed the domain struc-
methylrhamnose, and mycocerosic acids (Figure 2A). ture KS-AT-DH-ER-KR-ACP [47]. Homology searching
As mentioned earlier, this glycolipid was termed myco- suggested that the AT and KS domains may be involved
side B, the name mycoside being defined as a “type- in methylmalonyl-CoA versus malonyl-CoA substrate
specific glycolipid of mycobacterial origin” [5–7, 38]. selectivity. Both of the AT and KS domains of MAS
This type of mycoside is more correctly termed a glyco- showed selectivity for methylmalonyl-CoA over malonyl-
sylphenolphthiocerol dimycocerosate, and they are also CoA when overexpressed in Escherichia coli and Myco-
known as “phenolic glycolipids” [8, 9]. bacterium smegmatis (both hosts possess no MAS
activity), producing multimethyl-branched acids from
n-acyl primers [48].Biosynthesis of n-Fatty Acids
M. tuberculosis has both a multifunctional fatty acid Targeted disruption of mas from M. bovis BCG yielded
a mutant lacking mycocerosic acids (C29 and C32) andsynthase (FAS) type I, which is found predominately in
eukaryotes, and a dissociable multicomponent FAS type phenolic glycolipids, but still producing PDIMs with
shorter mycocerosic acids (C23 and C26) [49]. A recentII, found exclusively in prokaryotes and plants [40]. The
type I synthase catalyzes, in a bimodal distribution, the study has implicated a second enzyme from M. bovis
BCG, termed short-chain mycocerosic acids synthasede novo synthesis of C16-C18 and C24-C26 fatty acids [41].
Mycobacterial O-methylated polysaccharides appear to (SMAS), catalyzing the synthesis of such acids [50]. In-
terestingly, no thioesterase domain was found, nor astimulate the rate of fatty acid synthesis by FAS via
formation of a ternary complex with FAS I. An acyl-CoA mechanism, to account for chain termination in the syn-
thesis of mycocerosic acids. Mycocerosic acids synthe-substrate noncovalently binds to the synthase, enhanc-
ing the rate-limiting diffusion of the product [42]. As a sized by MAS are not released, suggesting that a specific
enzyme may be involved in transferring the mycocerosylconsequence, the release of C16-C18 fatty acids caused
by the O-methylated polysaccharides results not only group from MAS to the hydroxyl groups of phthiocerol
and phenolphthiocerol moieties (Figure 5). It had beenin the increased rate of fatty acid biosynthesis, but also
in a bimodal distribution in favor of C16-C18 fatty acids. postulated that an adjacent open reading frame (orf3)
to mas would possibly catalyze this process. A recentIt has been suggested [40–42] that mycobacterial FAS
I may function both as a de novo synthase and as an study has established that orf3 encodes a protein with
in vitro acyl-CoA synthase (ACoAS) activity, thereby per-elongase; however, in vivo it may primarily elongate host
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Figure 4. Structures of and Proposed Bio-
synthetic Pathways Leading to the Complex
Multimethyl-Branched Fatty Acids from M.
tuberculosis
See text for abbreviations.
forming CoA ester synthesis of n-C10-C18 fatty acids but Biosynthesis of Phthiocerols
and Phenolphthiocerolsnot mycocerosic acids [51]. In this study, the authors
failed to observe both mycocerosic acid activation and The biosynthesis of phthiocerol and phenolphthiocerol
would involve elongation of n-C20 acyl chains or an acylmycocerosic acid release from MAS and its transfer
to phthiocerols and phenolphthiocerols. More recent chain possessing a phenol residue at the  end. Chain
extension is presumed to occur initially using the appro-studies, where acoas was disrupted, produced a mutant
that lacked phenolic glycolipids, even though it pos- priate precursor and malonyl-CoA, followed by two suc-
cessive rounds using methylmalonyl-CoA, decarboxyl-sessed normal levels of mas activity [52]. The authors
suggested that this implicated ACoAS in the process of ation, and reduction. Overall, the biosynthesis probably
involves multifunctional synthases similar to FAS andesterification of phenolphthiocerols (and phthiocerols)
with mycocerosic acids. They argued against the possi- MAS, and analogous to those utilized for erythronolide
biosynthesis [53]. Using an approach based on domainbility that disruption of acoas affected the supply of
acyl-CoA primers to MAS. A number of highly similar organization and Southern hybridization experiments,
Azad et al. [54] identified a gene cluster, termed pps1-5acoas homologs are present near other polyketide syn-
thase (PKS)-like genes in the M. tuberculosis genome (and ppsA-E in M. tuberculosis [2]), that is required for
phthiocerol and phenolphthiocerol biosynthesis in M.and would compensate for the disruption of acoas un-
less a strict substrate-specificity existed. As discussed bovis BCG (Figure 5, annotated in the context of M.
tuberculosis). Further analyses established that the ppsabove, a second synthase, SMAS, exists in M. bovis
BCG and releases its products directly as free fatty cluster was downstream of the mas locus and tran-
scribed in the opposite direction (Figure 2C; see alsoacids. Thus, esterification to acceptors can take place
without the need for a separate ACoAS transferase activ- Figure 6). Disruption of the pps cluster and subsequent
biochemical analysis of the pps mutant established thatity. This would account for the continued synthesis of
PDIMs in the case of both the mas- and acoas- the gene cluster was involved in both phthiocerol and
phenolphthiocerol biosynthesis due to the absence ofdisrupted mutants.
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Figure 5. Structures of Phthiocerol and Phenolphthiocerol Families from the M. tuberculosis Complex and Proposed Pathways Leading to
Their Biosynthesis
Adapted from Azad et al. [54]. See text for abbreviations.
PDIMs and PGL [54]. The mutant possessed normal PDIMs and Virulent M. tuberculosis?
It has been recognized for some time that the distinctiveMAS activity as compared to the wild-type, ruling out
any indirect effect due to the disruption. nature of the cell wall of M. tuberculosis may be impor-
Figure 6. Domain Organization among pks Families from M. tuberculosis
(A) Known pks genes
(B) Unknown pks genes
The domain organization consists of the subunits -ketoacyl synthase (KS), acyl transferase (AT), dehydratase (DH), enoyl reductase (ER),
-ketoreductase (KR), acyl carrier protein (ACP), thioesterase (TE), and chalcone synthase-like (CHS?).
Review
551
tant for virulence. Cox et al. [55] and Camacho et al. Table 1. A Survey of Genomic Organization Surrounding pks
Genes in M. tuberculosis[56] isolated a number of mutants based upon signature-
tagged mutagenesis. The first mutant contained a Gene Designation Gene Length
transposon insertion in the promoter region of ppsA-E.
ppsA-E Rv2931-Rv2935 267,555The second contained an insertion in fadD28, presum-
mas Rv2940c 6,333
ably the ACoAS homolog described for M. bovis BCG mmpL7 Rv2942 2,760
involved in the transfer of mycocerosic acids to phthio- pks1 Rv2946c 4,848
cerols and phenolphthiocerols and adjacent to the M. pks15 Rv2947c 1,488
mmpL8 Rv3823c 3,267tuberculosis mas (Figure 2C). Biochemical analysis of
pks2 Rv3825c 6,378both mutants contained no detectable levels of PDIMs.
fadD23 Rv3826 1,752The analyses presented for the fadD28 mutant appear
pks3 Rv1180 1,464
to contradict the earlier findings in M. bovis BCG, where pks4 Rv1181 4,746
disruption led only to the absence of PGLs and contin- mmpL10 Rv1183 3,006
ued synthesis of PDIMs with shorter mycocerosic acids. fadD21 Rv1185c 1,734
mmpL12 Rv1522c 3,438This reaction is catalyzed by SMAS and an esterification
pks5 Rv1527c 6,324process independent of ACoAS [51]. Recent studies by
fadD24 Rv1529 1,752Camacho et al. [56] have shown that short-chain C26
fadD25 Rv1521 1,749
mycocerosic acids are absent from M. tuberculosis, ac- mmpL1 Rv0402c 2,874
counting for this discrepancy. A third mutant isolated mmpS1 Rv0403c 426
by Cox and colleagues [55], with a transposon insertion pks6 Rv0405 4,206
fadD30 Rv0404 1,755in mmpL7, accumulated normal levels of PDIMs in cells.
However, subsequent pulse-chase experiments estab-
lished that, unlike wild-type M. tuberculosis that pro-
duces a considerable amount of PDIMs in the culture The related phenolic glycolipid-1 (PGL-1) from M. leprae
medium, the mmpL7 mutant failed to liberate PDIM into has recently been shown to be a virulence factor through
the culture medium. Camacho et al. [56] have shown invasion of Schwann cells and determining the bacterial
that culture fluid production of PDIM by the wild-type predilection to the peripheral nerve [61].
strain is due to the use of Tween in the 7H9 medium.
This suggests that mmpL7 is involved in PDIM transport.
Biosynthesis of Phthioceranates, Mycosanoates,This is not surprising since mmpL7 is similar to actII-
and MycolipenatesORF3, which is involved in polyketide export in Strepto-
An ORF, which possessed the catalytic domains foundmyces coelicolor [57]. Interestingly, Camacho et al. [56]
in MAS, was predicted to be involved in methyl-obtained a similar phenotype with a mutant in drrC,
branched fatty acid biosynthesis by Sirakova et al. [62].suggesting that for correct localization of PDIM, the
The mas-like gene pks2 annotated in the M. tuberculosisMmpL7 and DrrABC transporters must interact for effi-
database [2] was subsequently disrupted and the mu-cient translocation. In addition, the PDIM mutants exhib-
tant analyzed for altered incorporation of [1-14C]propio-ited a more permeable cell wall that was more sensitive
nate into lipids. Two-dimensional thin-layer chromatog-to detergent, indicating that PDIM plays an important
raphy, followed by autoradiography, established that arole in maintaining the integrity of the cell envelope.
lipid coinciding with sulfolipids was missing in the pks2The hydrophobic Mmp proteins appear to be re-
mutant. Gas chromatography mass spectrometry (GC/stricted to mycobacteria, hence the designation “myco-
MS) and radio-GC established that the hydroxyphthio-bacterial membrane protein.” MmpL7 and other mem-
ceranic acids (heptamethyl C30, heptamethyl C32, octa-bers of the MmpL family are predicted to contain 12
methyl C32, and octamethyl C34) and phthioceranic acidsmembrane-spanning  helices organized in three clus-
found in sulfolipids (Figure 5) were the principal multi-ters [58]. This arrangement is reminiscent of that seen
methyl-branched fatty acids absent in the pks2 mutant.in the proton-dependent efflux proteins belonging to
It is possible that the initial transformation of a straight-the RND (resistance, nodulation, division) superfamily,
chain acid to the postulated -methyl--hydroxy acidsharing similar size and topology [59]. The RND super-
intermediate (Figure 4) is catalyzed by pks2. Disruptionfamily includes ActII-ORF3, involved in Streptomyces
of pks2 activity would then stop synthesis of both phthi-coelicolor polyketide export [57], and the SecDF type II
oceranic and hydroxyphthioceranic acids. Alternatively,secretion protein of Bacillus subtilis [60].
the same pks2 may be involved in the final elongationM. tuberculosis replicates extensively in the lungs
steps of both phthioceranic and hydroxyphthioceranicduring the first three weeks of infection. However, the
acids (Figure 4). The precise site of action of pks2 re-M. tuberculosis strains mutated in the pps-promoter,
mains to be clarified. Another intriguing aspect concernsfadD28 or mmpL7, showed severely restricted replica-
how the balance between the synthesis of phthioceraniction in the lungs of infected mice [55, 56]. Although
and hydroxyphthioceranic acids is controlled. An attrac-replication is greatest in the lungs, infection by intrave-
tive common pathway is shown in Figure 4, but separatenous injection also leads to seeding of M. tuberculosis
routes could operate. In such a common pathway, theinto other organs, such as the spleen and liver. All three
regulation of the dehydration and reduction of themutants had growth rates comparable with the wild-
-methyl--hydroxy acid intermediate (Figure 4) wouldtype in both of these organs. Thus, PDIM was suggested
be an important key process. The isolation of a sulfolipidas being a virulence factor specifically required for
growth of M. tuberculosis in the lungs of infected mice. mutant should pave the way forward to examining the
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of the mycosanoate/mycolipenate pathway (Figure 4).
These fatty acids have the same chirality as the phthio-
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